Martins WA, Magalhães Filho RJP, Galvão TFG. CAR-T Cells Therapy: What Cardiovascular Adverse Effects Should We Expect?. ABC: Heart Failure & Cardiomyopathy 2022;2(4):404-9.
Martins, Wolney de Andrade; Magalhães Filho, Roberto José Pessoa de; Galvão, Tatiana de Fátima Gonçalves. CAR-T Cells Therapy: What Cardiovascular Adverse Effects Should We Expect?. ABC: Heart Failure & Cardiomyopathy, v. 2, n. 4, p. 404-409, Dec. 2022.
Martins, W. A., Magalhães Filho, R. J. P. , & Galvão, T. F. G. (2022). CAR-T Cells Therapy: What Cardiovascular Adverse Effects Should We Expect?. ABC: Heart Failure & Cardiomyopathy, 2(4), 404-409.
Martins, Wolney de Andrade and Magalhães Filho, Roberto José Pessoa de and Galvão, Tatiana de Fátima Gonçalves. CAR-T Cells Therapy: What Cardiovascular Adverse Effects Should We Expect?. ABC: Heart Failure & Cardiomyopathy [online]. 2022, vol. 2, n. 4, [cited 2026-10-14], pp. 404-409. Available from: <https://journals.cardiol.br/en/article/car-t-cells-therapy-what-cardiovascular-adverse-effects-should-we-expect/>